Differential activation of CREB by Akt1 and Akt2

被引:26
|
作者
Kato, Satomi [1 ]
Ding, Jixin [1 ]
Du, Keyong [1 ]
机构
[1] Tufts Univ, New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA
关键词
Akt1; Akt2; PKB; CREB; gene expression; regulation;
D O I
10.1016/j.bbrc.2007.01.094
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Members of Akt family are highly conserved protein kinase and yet, they show clearly distinct in vivo functions. Here, we have examined the abilities of Akt1 and Akt2 to activate CREB. We found that, in contrast to Akt1 that induces CREB phosphorylation at Ser-133 and CREB target gene expression, Akt2 was unable to induce CREB phosphorylation at Ser-133 in vivo and CREB target gene expression. This difference is specific to CREB as both Akt1. and Akt2 similarly inhibits FoxO1 mediated gene expression. We further showed that the regulatory domain of Akt plays a critical role to confer Akt substrate specificity as substitution of regulatory domain of AktI with that of Akt2 abolished the ability of Akt1 to activate CREB. We suggest that the regulatory domain of Akts contributes to the functional difference between Akt1 and Akt2. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1061 / 1066
页数:6
相关论文
共 50 条
  • [1] Differential function of Akt1 and Akt2 in human adipocytes
    Fischer-Posovszky, Pamela
    Tews, Daniel
    Horenburg, Sina
    Debatin, Klaus-Michael
    Wabitsch, Martin
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2012, 358 (01) : 135 - 143
  • [2] Akt1 and Akt2: Differentiating the aktion
    Heron-Milhavet, Lisa
    Khouya, Nabil
    Fernandez, Anne
    Lamb, Ned J.
    HISTOLOGY AND HISTOPATHOLOGY, 2011, 26 (05) : 651 - 662
  • [3] Understanding the roles of AKT1 loss and AKT2 activation during SCC progression
    Button, R.
    Harwood, C.
    O'Shaughnessy, R. F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (09) : S302 - S302
  • [4] Akt1 and Akt2 are required for αβ thyrnocyte survival and differentiation
    Juntilla, Marisa M.
    Wofford, Jessica A.
    Birnbaum, Morris J.
    Rathmell, Jeffrey C.
    Koretzky, Gary A.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (29) : 12105 - 12110
  • [5] AKT1 AND AKT2 MEDIATE MALIGNANT FUNCTION IN GBM
    Joy, Anna
    Smirnov, Ivan
    Nakada, Mitsitoshi
    Rennert, Jessica
    Yeh, Ru-Fang
    Beaudry, Christian
    Zenklusen, Jean
    Fine, Howard
    Berens, Michael
    Feuerstein, Burt
    NEURO-ONCOLOGY, 2008, 10 (05) : 775 - 775
  • [6] Role of Akt1/Akt2 in Cardiac and Skeletal Muscle
    Kaneko, Kazuma
    Ueki, Kohjiro
    Umehara, Toshihiro
    Awazawa, Motoharu
    Sasako, Takayoshi
    Ohsugi, Misturu
    Birnbaum, Morris
    Kadowaki, Takashi
    DIABETES, 2011, 60 : A475 - A475
  • [7] Akt1/Akt2 inhibition and development of hepatocellular carcinoma
    Critelli, Rosina Maria
    Schepis, Filippo
    Villa, Erica
    TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S392 - S394
  • [8] Macrophage Deficiency of Akt2 or Both Akt1 and Akt2 Reduces Atherosclerosis: Akt is Critical for Macrophage Polarization and Survival
    Babaev, Vladimir R.
    Hebron, Katie E.
    Ding, Lei
    Zhang, Youmin
    May, James M.
    Fazio, Sergio
    Linton, MacRae F.
    CIRCULATION, 2013, 128 (22)
  • [9] The roles of Akt1 and Akt2 in GPIb-IX-mediated platelet activation signaling
    Yin, Hong
    Stojanovic, Aleksandra
    Hay, Nissim
    Du, Xiaoping
    BLOOD, 2007, 110 (11) : 1063A - 1063A
  • [10] Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation
    Trafalis, Dimitrios T.
    Sagredou, Sofia
    Dalezis, Panayiotis
    Voura, Maria
    Fountoulaki, Stella
    Nikoleousakos, Nikolaos
    Almpanakis, Konstantinos
    Deligiorgi, Maria V.
    Sarli, Vasiliki
    PHARMACEUTICS, 2021, 13 (04)